YD Bio (YDESW) Accumulated Expenses (2024 - 2026)

YD Bio (YDESW) has reported Accumulated Expenses for 3 consecutive years, with $333411.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accumulated Expenses fell 47.31% year-over-year to $333411.0 in Q2 2026; TTM through Jun 2026 was $333411.0, a 47.31% decrease from a year earlier, with the FY2025 full-year figure at $437859.0, up 140.11% from the prior year.
• Accumulated Expenses was $333411.0 for Q2 2026 at YD Bio, down from $437859.0 in the prior quarter.
• Over five years, Accumulated Expenses peaked at $632762.0 in Q2 2025 and troughed at $182360.0 in Q4 2024.
• A 3-year average of $396598.0 and a median of $385635.0 in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 140.11% in 2025 and sank 47.31% in 2026, its largest moves.
• Over 3 years, Accumulated Expenses stood at $182360.0 in 2024, then jumped by 140.11% to $437859.0 in 2025, then dropped by 23.85% to $333411.0 in 2026.
• The last three Accumulated Expenses figures came in at $333411.0 (Q2 2026), $437859.0 (Q4 2025), and $632762.0 (Q2 2025), per Business Quant data.